Inrig Jula
5 of 6 shown
The 5 most recent of 6 visible filings, newest first.
- Travere Therapeutics, Inc. EVP, Head of R&D & CMO32,395 sharesOption exercise
- Travere Therapeutics, Inc. EVP, Head of R&D & CMO$26,124Open-market sale
- Travere Therapeutics, Inc. EVP, Head of R&D & CMO$101,896Open-market sale
- Travere Therapeutics, Inc. EVP, Head of R&D & CMO$1,082,397Open-market sale
- Travere Therapeutics, Inc. EVP, Head of R&D & CMO$1,574,604Open-market sale